| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.007 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |